Related Experiment Videos
Protein synthesis inhibition is not a requisite for puromycin- and cycloheximide-induced c-myc mRNA superinduction
1Department of Haematology, School of Pathology, South African Institute for Medical Research.
Abstract:
The phenomenon of superinduction refers to the process by which high doses (30-180 microM) of the protein synthesis inhibitors Puromycin (PM) or Cycloheximide (CHX) augment and stabilize mRNA transcript levels through mechanisms which are dependent on the complete inhibition of protein synthesis. The current study undertaken in HL-60 leukaemic cells has dissociated the protein synthesis-inhibitory effects of PM and CHX from their c-myc mRNA superinducing effects. When employed at concentrations which were sub-inhibitory with respect to protein synthesis (0.2 microM), PM and CHX nevertheless elicited the phenomenon of superinduction, possibly through mechanisms related to intracellular signalling.
Insights
Puromycin (PM) and Cycloheximide (CHX) can superinduce c-myc mRNA at sub-inhibitory protein synthesis levels. This suggests intracellular signaling pathways, not just protein synthesis inhibition, drive mRNA stabilization.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Superinduction enhances and stabilizes mRNA transcripts.
- Protein synthesis inhibitors like Puromycin (PM) and Cycloheximide (CHX) typically require high doses for superinduction.
- These effects were previously thought to depend on complete protein synthesis inhibition.
Purpose of the Study:
- To investigate if PM and CHX can superinduce c-myc mRNA at sub-inhibitory protein synthesis concentrations.
- To dissociate the protein synthesis inhibitory effects from the mRNA superinducing effects of PM and CHX.
- To explore potential mechanisms underlying c-myc mRNA superinduction.
Main Methods:
- Utilizing HL-60 leukaemic cells.
- Employing sub-inhibitory concentrations (0.2 microM) of Puromycin (PM) and Cycloheximide (CHX).
- Measuring c-myc mRNA transcript levels and protein synthesis inhibition.
Main Results:
- PM and CHX at sub-inhibitory concentrations (0.2 microM) induced c-myc mRNA superinduction.
- These effects occurred despite minimal inhibition of protein synthesis.
- The study dissociated the protein synthesis-inhibitory action from the mRNA superinducing action of these drugs.
Conclusions:
- c-myc mRNA superinduction can be achieved without complete protein synthesis inhibition.
- Intracellular signaling pathways may play a crucial role in mediating PM- and CHX-induced superinduction.
- These findings offer new insights into the regulation of mRNA stability and gene expression.